A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients-Reference-Cited by-同舟云学术

A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients

Published:2022-05 Issue:3 Volume:12 Page:735-744
ISSN:0973-6883
Container-title:Journal of Clinical and Experimental Hepatology
language:en
Short-container-title:Journal of Clinical and Experimental Hepatology

Author:

Erken Robin^ORCID,Loukachov Vladimir V.,de Niet Annikki,Jansen Louis,Stelma Femke,Helder Jeltje T.,Peters Martine W.,Zaaijer Hans L.,Kootstra Neeltje A.^ORCID,Willemse Sophie B.,Reesink Hendrik W.

Publisher

Elsevier BV

Subject

Hepatology

Reference35 articles.

1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study;Razavi-Shearer;Lancet Gastroenterol Hepatol,2018

2. Safety and efficacy of 10mg (high-dose) bulevirtide (Myrcludex B) in combination with peg-interferon alpha 2a or tenofovir in patients with chronic HBV/HDV co-infection: week 24 interim results of the MYR203 extension study;Wedemeyer,2019

3. Electronic address eee, European association for the study of the L. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;J Hepatol,2017

4. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors;Fattovich;J Hepatol,2008

5. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance;Terrault;Hepatology,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review with network meta-analysis: sustained hepatitis B surface antigen clearance after pegylated interferon cessation;European Journal of Gastroenterology & Hepatology;2024-07-22

2. The incidence of hepatocellular carcinoma and clearance of hepatitis B surface for CHB patients in the indeterminate phase: a systematic review and meta-analysis;Frontiers in Cellular and Infection Microbiology;2023-09-12

3. Establishment of a multi-parameter prediction model for the functional cure of HBeAg-negative chronic hepatitis B patients treated with pegylated interferonα and decision process based on response-guided therapy strategy;BMC Infectious Diseases;2023-07-10

4. Establishment of a multi-parameter prediction model for the functional cure of HBeAg-negative chronic hepatitis B patients treated with pegylated interferonα and decision process based on response-guided therapy strategy;2023-03-14

5. Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study;Canadian Journal of Gastroenterology and Hepatology;2022-12-07